Contribution of β-adrenoceptor subtypes to relaxation of colon and oesophagus and pacemaker activity of ureter in wild-type and β3-adrenoceptor knockout mice

British Journal of Pharmacology

Volumn 130, Issue 4, 2000, Pages 747-758

  Oostendorp, Jaap ^a,e   Preitner, Frédéric ^b   Moffatt, James ^f   Jimenez, Maria ^b   Giacobino, Jean Paul ^b   Molenaar, Peter ^c   Kaumann, Alberto Julio ^a,d  

^a BABRAHAM INSTITUTE   (United Kingdom)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e UNIVERSITY OF GRONINGEN   (Netherlands)

^f University of Groningen ^*

Author keywords

( ) Adrenaline; ( ) CGP 12177; ( ) Noradrenaline; Colon; Oesophagus; Ureter

Indexed keywords

1 (2 ETHYLPHENOXY) 3 (1,2,3,4 TETRAHYDRO 1 NAPHTHYLAMINO) 2 PROPANOL OXALATE; 4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; ADRENALIN; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CARBACHOL; ISOPRENALINE; NORADRENALIN; POTASSIUM CHLORIDE; SPASMOLYTIC AGENT;

ARTICLE; COLON; ESOPHAGUS; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE RELAXATION; URETER;

EID: 0034091336     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703365     Document Type: Article

References (38)

1. 3 and atypical β-adrenoceptors (1993). Med. Res. Rev., 13, 663-729.
2. ARUNLAKSHANA, O. & SCHILD, H.O. (1959). Some quantitative uses of drug antagonists. Br. J. Pharmacol., 14, 48-58.
3. 2-selective adrenoceptor antagonist (ICI 118,551). J. Cardiovasc. Pharmacol., 5, 430-437.
4. 2-subtype. Br. J. Pharmacol., 110, 442-446.
5. 2+ transients in mouse ventricular myocytes. Naunyn-Schmiedeberg's Arch. Pharmacol., 360, 445-456.
6. 4-adrenoceptor. Br. J. Pharmacol., 122, 1244-1250.
7. 2-adrenoceptors of human heart. Differential antagonism of the positive inotropic effects and adenylate cyclase stimulation by (-)-noradrenaline and (-)-adrenaline. Naunyn-Schmiedeberg's Arch. Pharmacol., 331, 60-70.
8. 2-adrenoceptors in the rat vena cava: facilitation of noradrenaline release via local stimulation of angiotensin II synthesis. Naunyn-Schmiedeberg's Arch. Pharmacol., 334, 156-165.
9. KAUMANN, A.J. (1983). Cardiac β-adrenoceptors. Experimental viewpoints. Z. Kardiol., 72, 63-82.
10. KAUMANN, A.J. (1989). Is there a third heart β-adrenoceptor? Trends Pharmacol. Sci., 10, 316-320.
11. 4-like receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 342, 619-622.
12. KAUMANN, A.J. (1996). (-)-CGP 12177-induced increase of human atrial contraction through a putative third β-adrenoceptor. Br. J. Pharmacol., 117, 619-622.
13. KAUMANN, A.J. (1997). Four β-adrenoceptor subtypes in mammalian heart. Trends Pharmacol. Sci., 18, 70-76.
14. 3-adrenoceptor in the rat. Br. J. Pharmacol., 118, 2085-2098.
15. KAUMANN, A.J. & MOLENAAR, P. (1997). Modulation of human cardiac function through 4 β-adrenoceptor populations. Naunyn-Schmiedeberg's Arch. Pharmacol., 335, 667-681.
16. 2-adrenoceptor (AR) knockout mice. Proc. Austral. Soc. Clin. Exp. Pharmacol. Toxicol., 7, 70.
17. 3-adrenoccptor knockout mice. Mol. Pharmacol., 53, 670-675.
18. 3-adrenergic-independent effects of CGP 12177 in brown adipose tissue. Mol. Pharmacol., 57, 252-258.
19. 2-adrenoceptor-mediated positive inotropic effect possibly unrelated to cyclic AMP. Naunyn-Schmiedeberg's Arch. Pharmacol., 344, 56-69.
20. 3H-ICI 118,551 and blocking potency of ICI 118,551. Naunyn-Schmiedeberg's Arch. Pharmacol., 331, 40-51.
21. 1-adrenoceptors by carvedilol in ferret myocardium. Naunyn-Schmiedeberg's Arch. Pharmacol., 359, 400-403.
22. 2-adrenoceptor-mediated effects. Br. J. Pharmacol., 124, 1341-1344.
23. MAJEWSKI, H. (1983). Modulation of noradrenaline release through activation of presynaptic β-adrenoceptors. J. Auton. Pharmacol., 3, 47-60.
24. 3) β-adrenoceptors. Pharmacol. Comm., 6, 253-258.
25. 3-adrenoceptors. Br. J. Pharmacol., 120, 165-176.
26. 4-adrenoceptor' in mammalian heart. Clin. Exp. Pharmacol. Physiol., 24, 647-656.
27. MÜNCH, G., KURZ, T., URLBAUER, T., SEYFARTH, M. & RICHARDT, G. (1996). Differential presynaptic modulation of noradrenaline release in human atrial tissue in normoxia and anoxia. Br. J. Pharmacol., 118, 1855-1861.
28. MUSCHOLL, E. (1980). Peripheral muscarinic control of noradrenaline release in the cardiovascular system. Am. J. Physiol., 239, H713-H720.
29. 3H]-CGP 12177A for resolving subtype-selectivity of competitive ligands. Naunyn-Schmiedeberg's Arch. Pharmacol., 336, 519-525.
30. 1-adrenergic receptors. J. Recept. Signal. Tranduct. Res., 16, 1-23.
31. 3-adrenoceptor knockout mice: Evidence for a new β-adrenergic receptor in brown adipose tissue. Br. J. Pharmacol., 124, 1684-1688.
32. REVELLI, J.-P., PESCINI, R., MUZZIN, P., SEYDOUX, J., FITZGERALD, M.G., FRASER, C.M. & GIACOBINO, J.-P. (1991). Changes in beta 1-and beta 2-adrenergic receptor mRNA levels in brown adipose tissue and heart of hypothyroid rats. Biochem. J., 277, 625-629.
33. 3-adrenoceptor in the regulation of body composition. J. Clin. Invest., 100, 1098-1106.
34. 4-adrenoceptors in human atrium and ventricle. Naunyn-Schmiedeberg's Arch. Pharmacol., 358, R629.
35. 4-adrenoceptor' in rat atrium. Br. J. Pharmacol., 123, 371-380.
36. 3H]-CGP 12177 binding. Br. J. Pharmacol., 128, 1445-1460.
37. 3-adrenoceptor agonists of differing selectivities. J. Pharmacol. Exp. Ther., 285, 1084-1095.
38. TOMIYAMA, Y., HAYAKAWA, K., SHINAGAWA, K., AKAHANE, M., JISAWA, Y., PARK, Y.-C. & KURITA, T. (1998). β-Adrenoceptor subtypes in the ureteral smooth muscle of rats, rabbits and dogs. Eur. J. Pharmacol., 352, 269-278.